- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
172
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
172 companies
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,255.40
7D
6.4%
1Y
76.4%
Johnson & Johnson
Market Cap: US$651.3b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$270.24
7D
3.8%
1Y
50.7%
AbbVie
Market Cap: US$468.2b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$264.96
7D
6.2%
1Y
25.8%
Merck
Market Cap: US$376.4b
Operates as a healthcare company worldwide.
MRK
US$152.55
7D
12.3%
1Y
74.6%
AstraZeneca
Market Cap: UK£189.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£122.40
7D
6.8%
1Y
2.3%
Amgen
Market Cap: US$237.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$439.33
7D
5.8%
1Y
49.6%
Bristol-Myers Squibb
Market Cap: US$136.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$67.01
7D
5.0%
1Y
39.8%
Chugai Pharmaceutical
Market Cap: JP¥11.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,011.00
7D
1.1%
1Y
11.8%
Galderma Group
Market Cap: CHF 40.0b
Operates as a dermatology company worldwide.
GALD
CHF 171.55
7D
-0.8%
1Y
26.8%
Natera
Market Cap: US$47.9b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$332.03
7D
7.1%
1Y
100.5%
Jiangsu Hengrui PharmaceuticalsLtd
Market Cap: CN¥314.4b
A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
600276
CN¥47.74
7D
-9.3%
1Y
-26.5%
Haleon
Market Cap: UK£32.0b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.63
7D
2.1%
1Y
-0.4%
Teva Pharmaceutical Industries
Market Cap: US$43.5b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$37.34
7D
1.6%
1Y
102.3%
IQVIA Holdings
Market Cap: US$42.8b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$259.82
7D
9.8%
1Y
35.9%
Otsuka Holdings
Market Cap: JP¥6.4t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥12,195.00
7D
1.4%
1Y
51.2%
Sandoz Group
Market Cap: CHF 32.0b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 73.84
7D
1.2%
1Y
47.0%
Daiichi Sankyo Company
Market Cap: JP¥5.2t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,833.50
7D
3.8%
1Y
-23.4%
Biogen
Market Cap: US$32.0b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$216.78
7D
3.3%
1Y
55.6%
Astellas Pharma
Market Cap: JP¥4.3t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,387.00
7D
1.3%
1Y
41.0%
WuXi Biologics (Cayman)
Market Cap: HK$209.3b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.
2269
HK$51.00
7D
13.0%
1Y
54.9%
Hansoh Pharmaceutical Group
Market Cap: HK$200.6b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$33.08
7D
-0.7%
1Y
-9.7%
Innovent Biologics
Market Cap: HK$178.3b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$102.40
7D
9.2%
1Y
3.0%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$128.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$538.00
7D
3.4%
1Y
15.3%
Ipsen
Market Cap: €13.4b
A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.
IPN
€163.40
7D
4.7%
1Y
40.0%
Eurofins Scientific
Market Cap: €12.6b
Provides various analytical testing and laboratory services worldwide.
ERF
€72.84
7D
3.4%
1Y
6.6%
CSPC Pharmaceutical Group
Market Cap: HK$105.1b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.19
7D
5.8%
1Y
-12.6%
ICON
Market Cap: US$13.3b
A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.
ICLR
US$172.23
7D
5.6%
1Y
-2.0%
Tempus AI
Market Cap: US$13.1b
Operates as a healthcare technology company in the United States.
TEM
US$72.69
7D
39.5%
1Y
-9.7%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.8b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€52.85
7D
0.7%
1Y
0.8%
Arrowhead Pharmaceuticals
Market Cap: US$12.3b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$87.11
7D
0.5%
1Y
308.4%
Elanco Animal Health
Market Cap: US$12.0b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.97
7D
1.3%
1Y
33.8%
Zhangzhou Pientzehuang Pharmaceutical
Market Cap: CN¥74.9b
Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.
600436
CN¥124.10
7D
-6.4%
1Y
-42.1%
Akeso
Market Cap: HK$83.1b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$90.25
7D
-6.0%
1Y
-49.0%
Dr. Reddy's Laboratories
Market Cap: ₹978.8b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,175.00
7D
-2.2%
1Y
-8.0%
Krka d. d
Market Cap: €7.9b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€260.00
7D
0.6%
1Y
31.0%
Twist Bioscience
Market Cap: US$9.1b
Manufactures and sells synthetic DNA-based products.
TWST
US$145.59
7D
22.8%
1Y
409.2%